350
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

Understanding the mechanism of amygdalin’s multifunctional anti-cancer action using computational approach

& ORCID Icon
Pages 1600-1610 | Received 21 Dec 2019, Accepted 19 Feb 2020, Published online: 09 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sandra Jose, Sreevidya S. Devi, Shakthi P.Khattab Al-Khafaji. (2022) Phytochemical constituents of Inula britannica as potential inhibitors of dihydrofolate reductase: A strategic approach against shigellosis. Journal of Biomolecular Structure and Dynamics 40:22, pages 11932-11947.
Read now
Bilal J. M. Aldahham, Khattab Al-Khafaji, Mohanad Yakdhan Saleh, Adel Mohamed Abdelhakem, Amer M. Alanazi & Md Ataul Islam. (2022) Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study. Journal of Biomolecular Structure and Dynamics 40:9, pages 3899-3906.
Read now
Khattab Al-Khafaji & Tugba Taskin Tok. (2021) Amygdalin as multi-target anticancer drug against targets of cell division cycle: double docking and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 39:6, pages 1965-1974.
Read now

Articles from other publishers (9)

Ahmed Mohammed Alwan & Jalil Tavakol Afshari. (2023) Investigating the Protective Role of Rhodanese Enzyme against Cyanide, the Cytotoxic by-product of Amygdalin, in HDF and L929 Cell Lines. Letters in Drug Design & Discovery 20:9, pages 1295-1307.
Crossref
Ahmed Mohammed Alwan, Dinesh Rokaya, Goma Kathayat & Jalil Tavakol Afshari. (2023) Onco-immunity and therapeutic application of amygdalin: A review. Journal of Oral Biology and Craniofacial Research 13:2, pages 155-163.
Crossref
Zaid Jaafar Awad AL-NUAİMİ, Abuzer ÇELEKLİ & Tugba TASKIN TOK. (2022) Computational Approaches for Drug Repurposing in Alzheimer's DiseaseAlzheimer Hastalığında İlacın Yeniden Kullanım İçin Hesaplamalı Yaklaşımlar. Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi 25:Ek Sayı 2, pages 307-315.
Crossref
Yassine Kaddouri, Btissam Bouchal, Farid Abrigach, Mohamed El Kodadi, Mohammed Bellaoui, Ahmed Elkamhawy, Rachid Touzani & Magda H. Abdellattif. (2022) New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties. Pharmaceuticals 15:7, pages 803.
Crossref
Md. Oliullah Rafi, Khattab Al-Khafaji, Md. Takim Sarker, Tugba Taskin-Tok, Abdus Samad Rana & Md. Shahedur Rahman. (2022) Design of a multi-epitope vaccine against SARS-CoV-2: immunoinformatic and computational methods. RSC Advances 12:7, pages 4288-4310.
Crossref
H. El-Mageed, Doaa Abdelrheem, Md. Rafi, Md. Sarker, Khattab Al-Khafaji, Md. Hossain, Raffaele Capasso & Talha Emran. (2021) In Silico Evaluation of Different Flavonoids from Medicinal Plants for Their Potency against SARS-CoV-2. Biologics 1:3, pages 416-434.
Crossref
Rasel Ahmed Khan, Rajib Hossain, Abolghasem Siyadatpanah, Khattab Al-Khafaji, Abul Bashar Ripon Khalipha, Dipta Dey, Umma Hafsa Asha, Partha Biswas, Abu Saim Mohammad Saikat, Hadi Ahmadi Chenari, Polrat Wilairatana & Muhammad Torequl Islam. (2021) Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study. Molecules 26:22, pages 6821.
Crossref
Eldar Muhtar, Mengyang Wang & Haimei Zhu. (2021) In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database . Future Virology 16:8, pages 507-518.
Crossref
Rajib Hossain, Khattab Al-Khafaji, Rasel Ahmed Khan, Chandan Sarkar, Md. Shahazul Islam, Dipta Dey, Divya Jain, Farhana Faria, Rukaya Akbor, Olubunmi Atolani, Sónia M. R. Oliveira, Abolghasem Siyadatpanah, Maria de Lourdes Pereira & Muhammad Torequl Islam. (2021) Quercetin and/or Ascorbic Acid Modulatory Effect on Phenobarbital-Induced Sleeping Mice Possibly through GABAA and GABAB Receptor Interaction Pathway. Pharmaceuticals 14:8, pages 721.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.